Dr. Debra A. Ferman, MD
- Part D claims, 2024
- 603
- Publications
- 3
- Clinical trials
- 1
- Hospital affiliations
- 1
- Industry payments
- $2,135
- Practice address
- 82-68 164th Street, Jamaica, NY 11432
- Practice phone
- Call (718) 883-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Ferman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Debra A. Ferman is a hematologist and oncologist in Jamaica, New York
Dr. Ferman practices at NYC Health + Hospitals/Queens in Jamaica, New York, part of NYC.
Dr. Ferman's NPI, 1881693216, was assigned on July 18, 2005. Dr. Ferman holds New York license 221216.
- NPI
- 1881693216NPI Registry (opens in a new tab)
- NPI enumeration date
- July 18, 2005
- NPI status
- Active
- Practice phone
- (718) 883-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Debra A. Ferman practices at NYC Health + Hospitals/Queens in Jamaica, New York
Dr. Ferman's primary practice is NYC Health + Hospitals/Queens, at 82-68 164th Street, Jamaica, NY 11432 in Queens County. The practice phone is (718) 883-3000.
- NYC Health + Hospitals/Queens82-68 164th Street, Jamaica, NY 11432 · Queens CountyPhone(718) 883-3000
Source: Dmand AI Affiliation Data
Dr. Debra A. Ferman is affiliated with 1 site of care and 2 medical groups
Dr. Ferman's primary practice is NYC Health + Hospitals/Queens in Jamaica, New York, part of NYC. The medical group on file is NYC Health + Hospitals. Dmand AI also links Dr. Ferman to 1 more medical group, named with a free account. Dr. Ferman's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Debra A. Ferman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ferman practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| NYC Health + Hospitals/Queens | Available with a free account |
| +1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across NYC and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Debra A. Ferman is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Ferman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ferman is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Ferman
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Debra A. Ferman's patients have a median age of 67
Across all payers, Dmand AI patient panel data puts Dr. Ferman's median patient age at 67, with 66% women.
Dr. Ferman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women66%
- Men34%
Source: Dmand AI Patient Panel Data
Dr. Debra A. Ferman wrote 603 Medicare Part D claims in 2024
In 2024, Dr. Ferman wrote 603 Medicare Part D claims for 85 patients. 80% of them were for generic drugs. CMS names the drug for 398 of them, across 16 drugs with 11 or more claims each, at $490,394 in total drug cost. In 2023, CMS named 231 claims across 9 drugs.
Dr. Ferman's Part D claims by kind of drug, 2024
- Generic483 claims80%
- Brand-name and other120 claims20%
Dr. Ferman's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Ferman's Part D claims, 2024
- Opioids4%22 of 603 claims
- Antibiotics2%12 of 603 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2312024: 39872%
Drugs named by CMS: 16 in 2024, 9 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Debra A. Ferman has 3 publications on record
Dmand AI links 3 papers to Dr. Ferman, published from 2021 to 2024. 2021 was the busiest year, with 2. Dr. Ferman has published most often in Cureus. Dr. Ferman's most frequent co-authors are Patricia A. Shi, MD and Sandeep Singh Tuli, DO.
Dr. Ferman's most frequent co-authors
Recent publications by Dr. Ferman
See who Dr. Ferman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ferman works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Debra A. Ferman has worked on 1 clinical trial
Dmand AI links Dr. Ferman to 1 clinical trial. Conditions studied include Priapism and Penile Diseases.
Conditions in Dr. Ferman's trials
- Priapism
- Penile Diseases
Investigators on the most trials with Dr. Ferman
- Biree Andemariam, MD1 shared trial
- Alan Randall Anderson, MD1 shared trial
- Shayla Marie Bergmann, MD1 shared trial
Recent clinical trials with Dr. Ferman
A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Debra A. Ferman received $2,135 in industry payments from 2016 to 2025
CMS Open Payments shows 21 general payments to Dr. Ferman from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 52% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,380.
General payments to Dr. Ferman by program year, 2016 to 2025
General payments to Dr. Ferman by kind, 2016 to 2025
- Travel and lodging$1,12052%
- Food and beverage$95445%
- Education$613%
Companies that paid Dr. Ferman the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Debra A. Ferman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Debra A. Ferman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Debra A. Ferman's NPI number?
Dr. Debra A. Ferman's NPI number is 1881693216. It was assigned on July 18, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Debra A. Ferman?
Dr. Debra A. Ferman is a hematologist and oncologist in Jamaica, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Debra A. Ferman practice?
Dr. Ferman practices at 82-68 164th Street, Jamaica, NY 11432. Dr. Ferman's primary practice is NYC Health + Hospitals/Queens in Jamaica, New York, part of NYC. Dmand AI also links Dr. Ferman to 1 medical group.
What is Dr. Debra A. Ferman's office phone number?
The practice phone on file for Dr. Ferman is (718) 883-3000.
What is Dr. Debra A. Ferman's medical license number?
Dr. Ferman holds New York license 221216.
Which hospitals is Dr. Debra A. Ferman affiliated with?
Dr. Ferman practices at NYC Health + Hospitals/Queens in Jamaica, New York.
What medical group is Dr. Debra A. Ferman part of?
Dr. Ferman is linked to NYC Health + Hospitals. Dmand AI links Dr. Ferman to 1 more medical group.
What drugs does Dr. Debra A. Ferman prescribe most?
In 2024 Medicare Part D data, Dr. Ferman's most prescribed drugs by claims were Anastrozole, Ondansetron HCl and Letrozole.
Has Dr. Debra A. Ferman received payments from drug or device companies?
CMS Open Payments shows $2,135 in general payments to Dr. Ferman from 12 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Debra A. Ferman been practicing?
Dr. Ferman's NPI was assigned in 2005.
Does Dr. Debra A. Ferman do research?
Dmand AI links 3 publications to Dr. Ferman, published from 2021 to 2024. Dr. Ferman has worked on 1 clinical trial.
Who does Dr. Debra A. Ferman publish with?
Dr. Ferman's most frequent co-authors are Patricia A. Shi, MD (1 shared paper) and Sandeep Singh Tuli, DO (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card